Report of consensus panel 2 from the 11th international workshop on Waldenström's macroglobulinemia on the management of relapsed or refractory WM patients
D'Sa, S, Matous, J V, Advani, R, Buske, C, Castillo, J J, Gatt, M, Kapoor, P, Kersten, M J, Leblond, V, Leiba, M, Palomba, M L, Paludo, J, Qiu, L, Sarosiek, S, Shadman, M, Talaulikar, D, Tam, C S, Tedeschi, A, Thomas, S K, Tohidi-Esfahani, I, Trotman, J, Varettoni, M, Vos, Jmi, Garcia-Sanz, R, San-Miguel, J, Dimopoulos, M A, Treon, S P, Kastritis, E
Published in Seminars in hematology (01.03.2023)
Published in Seminars in hematology (01.03.2023)
Get more information
Journal Article
Report of consensus panel 7 from the 11th international workshop on Waldenström macroglobulinemia on priorities for novel clinical trials
Tam, C S, Kapoor, P, Castillo, J J, Buske, C, Ansell, S M, Branagan, A R, Kimby, E, Li, Y, Palomba, M L, Qiu, L, Shadman, M, Abeykoon, J P, Sarosiek, S, Vos, Jmi, Yi, S, Stephens, D, Roos-Weil, D, Roccaro, A M, Morel, P, Munshi, N C, Anderson, K C, San-Miguel, J, Garcia-Sanz, R, Dimopoulos, M A, Treon, S P, Kersten, M J
Published in Seminars in hematology (01.03.2023)
Published in Seminars in hematology (01.03.2023)
Get more information
Journal Article
ERK1/2 pro-survival signalling is suppressed by pirtobrutinib in ibrutinib-resistant MYD88-mutated lymphoma cells
Munshi, M, Liu, X, Kofides, A, Tsakmaklis, N, Hunter, Z R, Guerrera, M L, Canning, A, Gustine, J N, Liu, S, Hatcher, J M, Chen, J, Meid, K, Sarosiek, S, Flynn, C A, Branagan, A R, von Keudell, G, Palomba, L M, Castillo, J J, Yang, G, Treon, S P
Published in British journal of haematology (18.09.2024)
Published in British journal of haematology (18.09.2024)
Get full text
Journal Article
Targeted mutational profiling of peripheral T-cell lymphoma not otherwise specified highlights new mechanisms in a heterogeneous pathogenesis
Schatz, J H, Horwitz, S M, Teruya-Feldstein, J, Lunning, M A, Viale, A, Huberman, K, Socci, N D, Lailler, N, Heguy, A, Dolgalev, I, Migliacci, J C, Pirun, M, Palomba, M L, Weinstock, D M, Wendel, H-G
Published in Leukemia (01.01.2015)
Published in Leukemia (01.01.2015)
Get full text
Journal Article
A Phase I Study of CD19‐targeted 19(T2)28z1xx CAR T Cells in Adult Patients with Relapsed or Refractory Diffuse Large B‐cell Lymphoma
Palomba, M. L., Riviere, I., Sikder, D. S., Senechal, B., Wang, X., Cathcart, E. R., Liotta, K., Li, J., Sellner, L., Sadelain, M., Chen, S., Zhao, Y., Park, J. H.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
Clonal B cells in Waldenström’s macroglobulinemia exhibit functional features of chronic active B-cell receptor signaling
Argyropoulos, K V, Vogel, R, Ziegler, C, Altan-Bonnet, G, Velardi, E, Calafiore, M, Dogan, A, Arcila, M, Patel, M, Knapp, K, Mallek, C, Hunter, Z R, Treon, S P, van den Brink, M R M, Palomba, M L
Published in Leukemia (01.05.2016)
Published in Leukemia (01.05.2016)
Get full text
Journal Article
IMPACT OF RESPONSE TO SYSTEMIC BRIDGING THERAPY ON CLINICAL OUTCOMES AND CYTOKINE PROFILE IN PATIENTS RECEIVING CAR T‐CELL THERAPY FOR AGGRESSIVE B‐CELL LYMPHOMA
Wills, B., Shouval, R., Flynn, J., Devlin, S. M., Shah, G. L., Scordo, M., P. B. Dahi, Lin, R. J., Imber, B., Parascondola, A., Saldia, A., Landego, I., Ip, A., Leslie, L., Suh, H., Salles, G., Perales, M., Palomba, M. L.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
Tumor-infiltrating and circulating granulocytic myeloid-derived suppressor cells correlate with disease activity and adverse clinical outcomes in mycosis fungoides
Argyropoulos, K. V., Pulitzer, M., Perez, S., Korkolopoulou, P., Angelopoulou, M., Baxevanis, C., Palomba, M. L., Siakantaris, M.
Published in Clinical & translational oncology (01.07.2020)
Published in Clinical & translational oncology (01.07.2020)
Get full text
Journal Article
LISOCABTAGENE MARALEUCEL (LISO‐CEL) IN R/R MCL: PRIMARY ANALYSIS RESULTS FROM THE MCL COHORT OF THE SINGLE‐ARM, MULTICENTER, SEAMLESS DESIGN TRANSCEND NHL 001 STUDY
Wang, M., Siddiqi, T., Gordon, L. I., Kamdar, M., Lunning, M., Hirayama, A. V., Abramson, J. S., Arnason, J., Ghosh, N., Mehta, A., Andreadis, C., Solomon, S. R., Kostic, A., Dehner, C., Espinola, R., Peng, L., Ogasawara, K., Chattin, A., Palomba, M. L.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
DYNAMICS OF RADIOMIC FEATURES FOLLOWING BRIDGING THERAPY DETERMINE CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) T‐CELL THERAPY OUTCOME
Imber, B. S., Silverman, E. A., Leithner, D., Hubbeling, H., Shah, G. L., Fregonese, B., Sanin, B. W., Tomas, A. A., Parascondola, A., Saldia, A., Landego, I., Dahi, P. B., Giralt, S., Lin, R. J., Scordo, M., Salles, G., Yahalom, J., Palomba, M. L., Schoder, H., Perales, M., Shouval, R.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
CNS radiotherapy as bridging prior to CAR T‐cell therapy for hematologic malignancies
Cederquist, G., Hubbeling, H., Tringale, K., Shah, G., Tomas, A. Alarcon, Shouval, R., Hajj, C., Fregonese, B., Lee, J., Dahi, P. B., Lin, R. J., Palomba, M. L., Perales, M., Salles, G., Falchi, L., Grommes, C., Scordo, M., Yahalom, J., Imber, B. S.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
PET‐Adapted Therapy with Nivolumab plus Adriamycin, Vinblastine, and Dacarbazine for Newly Diagnosed Stage III or IV Hodgkin Lymphoma
Moskowitz, A., Savage, K., Feldman, T., Ganesan, N., Hancock, H., Davey, T., Perez, L., Santarosa, A., Subzwari, S., Capadona, C., Yang, C., Galasso, N., David, K., Epstein‐Peterson, Z., Khan, N., Kumar, A., Hamlin, P., Ghione, P., Lue, J., Straus, D., Zelenetz, A., Owens, C., Caron, P., Intlekofer, A., Horwitz, S., Falchi, L., Johnson, W., Palomba, M. L., Noy, A., Salles, G., Torka, P., Vardhana, S., Yahalom, J., Dogan, A., Schoder, H.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
TRANSCEND FL: PHASE 2 STUDY RESULTS OF LISOCABTAGENE MARALEUCEL (LISO‐CEL) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL)
Morschhauser, F., Dahiya, S., Palomba, M. L., Garcia‐Sancho, A. M., Ortega, J. L. Reguera, Kuruvilla, J., Jager, U., Cartron, G., Izutsu, K., Dreyling, M., Kahl, B., Ghesquieres, H., Ardeshna, K., Goto, H., Barbui, A. M., Abramson, J. S., Borchmann, P., Fleury, I., Mielke, S., Farazi, T., Fasan, O., Lymp, J., Vedal, M., Nishii, R., Avilion, A., Papuga, J., Nastoupil, L. J.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
LONG‐TERM FOLLOW‐UP OF MULTICENTER PHASE II TRIAL OF ZANUBRUTINIB, OBINUTUZUMAB, AND VENETOCLAX (BOVEN) IN PREVIOUSLY UNTREATED PATIENTS WITH CLL/SLL
Soumerai, J. D., Dogan, A., Seshan, V., Flaherty, K., Carter, J., Hochberg, E., Barnes, J. A., Abramson, J. S., Hamilton, A. M., Noy, A., Owens, C. N., Palomba, M. L., Kumar, A., Roeker, L. E., Thompson, M., Takvorian, R. W., Epstein‐Peterson, Z., Geyer, M., Ramos‐Amador, W., Mahajan, N., Martignetti, R., Plummer, S. F., Mi, J., Lynch, J. M., McGree, B. M., Sherburne, M. M., Patterson, E. N., Slupe, N., Chabowska, M., Labarre, A., Choma, M., McCambridge, G., Kelly, H., Devlin, M. C., Puccio, M. G., Garcia, R. N., Grieve, C., Cohen, A., Biondo, J., Jacob, A., Abdel‐Wahab, O., Zelenetz, A. D.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
OUTCOMES IN LATER‐LINES OF THERAPY FOR RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: RESULTS FROM THE INTERNATIONAL SCHOLAR‐5 STUDY
Ghione, P., Ghesquieres, H., Bobillo, S., Patel, A. R., Kanters, S., Deighton, K., Dong, H., Yang, Y., Ma, L., Limbrick‐Oldfield, E. H., Thornton Snider, J., Wade, S. W., Riberio, M. T., Sudhindra, A., Radford, J., Palomba, M. L., Gribben, J.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
Noninvasive Monitoring of Mantle Cell Lymphoma by Immunoglobulin Gene Next-Generation Sequencing in a Phase 2 Study of Sequential Chemoradioimmunotherapy Followed by Autologous Stem-Cell Rescue
Kumar, Anita, Bantilan, K.S., Jacob, A.P., Park, A., Schoninger, S.F., Sauter, C., Ulaner, G.A., Casulo, C., Faham, M., Kong, K.A., Grewal, R.K., Gerecitano, J., Hamilton, A., Hamlin, P., Matasar, M., Moskowitz, C.H., Noy, A., Palomba, M.L., Portlock, C.S., Younes, A., Willis, T., Zelenetz, A.D.
Published in Clinical lymphoma, myeloma and leukemia (01.04.2021)
Published in Clinical lymphoma, myeloma and leukemia (01.04.2021)
Get full text
Journal Article
CLINICAL OUTCOMES AND THE ROLE OF OBSERVATION IN EARLY‐STAGE FOLLICULAR LYMPHOMA
Sha, F., Okwali, M., Alperovich, A., Caron, P. C., Falchi, L., Hamilton, A., Hamlin, P. A., Horwitz, S. M., Joffe, E., Kumar, A., Matasar, M. J., Moskowitz, A. J., Noy, A., Owens, C., Palomba, L. M., Rodriguez‐Rivera, I., Straus, D., von Keudell, G., Zelenetz, A. D., Yahalom, J., Dogan, A., Schoder, H., Seshan, V. E., Salles, G., Younes, A., Batlevi, C. L.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
S262: THE COBALT‐LYM STUDY OF CTX130: A PHASE 1 DOSE ESCALATION STUDY OF CD70‐TARGETED ALLOGENEIC CRISPR‐CAS9–ENGINEERED CAR T CELLS IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) T‐CELL MALIGNANCIES
Iyer, S. P., Sica, R. A., Ho, P. J., Hu, B., Zain, J., Prica, A., Weng, W.‐K., Kim, Y. H., Khodadoust, M. S., Palomba, M. L, Foss, F. M., Tipton, K., Cullingford, E. L., He, Q., Sharma, A., Horwitz, S. M.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article